ISG15 deficiency and increased viral resistance in humans but not mice

Nature Communications

Volumn 7, Issue , 2016, Pages

  Speer, Scott D ^a   Li, Zhi ^b   Buta, Sofija ^a   Payelle Brogard, Béatrice ^b   Qian, Li ^a   Vigant, Frederic ^a   Rubino, Erminia ^b   Gardner, Thomas J ^a   Wedeking, Tim ^c   Hermann, Mark ^a   Duehr, James ^a   Sanal, Ozden ^d   Tezcan, Ilhan ^d   Mansouri, Nahal ^e   Tabarsi, Payam ^e   Mansouri, Davood ^e   Francois Newton, Véronique ^b   Daussy, Coralie F ^b   Rodriguez, Marisela R ^f   Lenschow, Deborah J ^a   Freiberg, Alexander N ^f   Tortorella, Domenico ^g   Piehler, Jacob ^a   Lee, Benhur ^c   García Sastre, Adolfo ^a   Pellegrini, Sandra ^b   Bogunovic, Dusan ^a   more..

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CNRS   (France)

^c UNIVERSITY OF OSNABRÜCK   (Germany)

^d HACETTEPE UNIVERSITY   (Turkey)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON DERIVATIVE; INTERFERON STIMULATED GENE 15; TETRATRICOPEPTIDE REPEAT PROTEIN; TETRATRICOPEPTIDE REPEATS 1; UNCLASSIFIED DRUG; CYTOKINE; G1P2 PROTEIN, MOUSE; INTERFERON; ISG15 PROTEIN, HUMAN; UBIQUITIN; UBIQUITIN THIOLESTERASE; USP18 PROTEIN, MOUSE;

ANTIMICROBIAL ACTIVITY; DISEASE RESISTANCE; GENE; HUMAN ACTIVITY; IMMUNITY; PROTEIN; RODENT; VIRAL DISEASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE PREDISPOSITION; EMBRYO; FEMALE; FIBROBLAST; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNOPRECIPITATION; INFECTION PREVENTION; INFLUENZA A; INFLUENZA A VIRUS; ISG15 DEFICIENCY; MOUSE; NIPAH VIRUS; NIPAH VIRUS INFECTION; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; VIRUS ATTENUATION; VIRUS INFECTION; VIRUS REPLICATION; VIRUS RESISTANCE; ANIMAL; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PRIMARY CELL CULTURE;

MUS;

ANIMALS; CELL LINE; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERONS; MICE; PRIMARY CELL CULTURE; UBIQUITIN THIOLESTERASE; UBIQUITINS; VIRUS DISEASES;

EID: 84970959689     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11496     Document Type: Article

References (59)

1. Narasimhan, J. et al. Crystal structure of the interferon-induced ubiquitin-like protein ISG15. J. Biol. Chem. 280, 27356-27365 (2005).
2. Farrell, P. J., Broeze, R. J. & Lengyel, P. Accumulation of an mRNA and protein in interferon-Treated Ehrlich ascites tumour cells. Nature 279, 523-525 (1979).
3. Korant, B. D., Blomstrom, D. C., Jonak, G. J. & Knight, Jr. E. Interferoninduced proteins. Purification and characterization of a 15, 000-dalton protein from human and bovine cells induced by interferon. J. Biol. Chem. 259, 14835-14839 (1984).
4. Blomstrom, D. C., Fahey, D., Kutny, R., Korant, B. D. & Knight, Jr. E. Molecular characterization of the interferon-induced 15-kDa protein. Molecular cloning and nucleotide and amino acid sequence. J. Biol. Chem. 261, 8811-8816 (1986).
5. Reich, N. et al. Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc. Natl Acad. Sci. USA 84, 6394-6398 (1987).
6. Kessler, D. S., Levy, D. E. & Darnell, Jr. J. E. Two interferon-induced nuclear factors bind a single promoter element in interferon-stimulated genes. Proc. Natl Acad. Sci. USA 85, 8521-8525 (1988).
7. Knight, Jr. E. et al. A 15-kDa interferon-induced protein is derived by COOH-Terminal processing of a 17-kDa precursor. J. Biol. Chem. 263, 4520-4522 (1988).
8. Durfee, L. A. & Huibregtse, J. M. Identification and validation of ISG15 target proteins. Subcell. Biochem. 54, 228-237 (2010).
9. Bogunovic, D. et al. Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency. Science 337, 1684-1688 (2012).
10. Zhang, X. et al. Human intracellular ISG15 prevents interferon-Alpha/beta over-Amplification and auto-inflammation. Nature 517, 89-93 (2015).
11. Zhang, D. & Zhang, D. E. Interferon-stimulated gene 15 and the protein ISGylation system. J. Interferon Cytokine Res. 31, 119-130 (2011).
12. Basters, A. et al. Molecular characterization of ubiquitin-specific protease 18 reveals substrate specificity for interferon-stimulated gene 15. FEBS J. 281, 1918-1928 (2014).
13. Malakhova, O. A. et al. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J. 25, 2358-2367 (2006).
14. Lenschow, D. J. et al. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc. Natl Acad. Sci. USA 104, 1371-1376 (2007).
15. Hsiao, N. W. et al. ISG15 over-expression inhibits replication of the Japanese encephalitis virus in human medulloblastoma cells. Antiviral Res. 85, 504-511 (2010).
16. Guerra, S., Caceres, A., Knobeloch, K. P., Horak, I. & Esteban, M. Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog. 4, e1000096 (2008).
17. Werneke, S. W. et al. ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog. 7, e1002322 (2011).
18. Rodriguez, M. R., Monte, K., Thackray, L. B. & Lenschow, D. J. ISG15 functions as an interferon-mediated antiviral effector early in the murine norovirus life cycle. J. Virol. 88, 9277-9286 (2014).
19. Osiak, A., Utermohlen, O., Niendorf, S., Horak, I. & Knobeloch, K. P. ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol. Cell. Biol. 25, 6338-6345 (2005).
20. Zhang, Y., Burke, C. W., Ryman, K. D. & Klimstra, W. B. Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J. Virol. 81, 11246-11255 (2007).
21. Malakhova, O. A. & Zhang, D. E. ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J. Biol. Chem. 283, 8783-8787 (2008).
22. Dai, J., Pan, W. & Wang, P. ISG15 facilitates cellular antiviral response to dengue and west nile virus infection in vitro. Virol. J. 8, 468 (2011).
23. Tang, Y. et al. Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein. J. Immunol. 184, 5777-5790 (2010).
24. Kuang, Z., Seo, E. J. & Leis, J. Mechanism of inhibition of retrovirus release from cells by interferon-induced gene ISG15. J. Virol. 85, 7153-7161 (2011).
25. Okumura, A., Lu, G., Pitha-Rowe, I. & Pitha, P. M. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc. Natl Acad. Sci. USA 103, 1440-1445 (2006).
26. Pincetic, A., Kuang, Z., Seo, E. J. & Leis, J. The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J. Virol. 84, 4725-4736 (2010).
27. Okumura, A., Pitha, P. M. & Harty, R. N. ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc. Natl Acad. Sci. USA 105, 3974-3979 (2008).
28. Durfee, L. A., Lyon, N., Seo, K. & Huibregtse, J. M. The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol. Cell 38, 722-732 (2010).
29. Shi, H. X. et al. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol. Cell. Biol. 30, 2424-2436 (2010).
30. Broering, R. et al. The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response. Gut 59, 1111-1119 (2010).
31. Chua, P. K. et al. Modulation of alpha interferon anti-hepatitis C virus activity by ISG15. J. Gen. Virol. 90, 2929-2939 (2009).
32. Francois-Newton, V., Livingstone, M., Payelle-Brogard, B., Uze, G. & Pellegrini, S. USP18 establishes the transcriptional and anti-proliferative interferon alpha/beta differential. Biochem. J. 446, 509-516 (2012).
33. Lai, C. et al. Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-Adapted and non-mouse-Adapted influenza B virus infection. J. Virol. 83, 1147-1151 (2009).
34. Bogunovic, D., Boisson-Dupuis, S. & Casanova, J. L. ISG15: leading a double life as a secreted molecule. Exp. Mol. Med. 45, e18 (2013).
35. Lochte, S., Waichman, S., Beutel, O., You, C. & Piehler, J. Live cell micropatterning reveals the dynamics of signaling complexes at the plasma membrane. J. Cell Biol. 207, 407-418 (2014).
36. Hertzog, P. J. & Williams, B. R. Fine tuning type I interferon responses. Cytokine Growth Factor Rev. 24, 217-225 (2013).
37. Ivashkiv, L. B. & Donlin, L. T. Regulation of type I interferon responses. Nat. Rev. Immunol. 14, 36-49 (2014).
38. Porritt, R. A. & Hertzog, P. J. Dynamic control of type I IFN signalling by an integrated network of negative regulators. Trends Immunol. 36, 150-160 (2015).
39. Yuan, W. & Krug, R. M. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 20, 362-371 (2001).
40. Zhao, C., Collins, M. N., Hsiang, T. Y. & Krug, R. M. Interferon-induced ISG15 pathway: An ongoing virus-host battle. Trends Microbiol. 21, 181-186 (2013).
41. Versteeg, G. A. et al. Species-specific antagonism of host ISGylation by the influenza B virus NS1 protein. J. Virol. 84, 5423-5430 (2010).
42. Guan, R. et al. Structural basis for the sequence-specific recognition of human ISG15 by the NS1 protein of influenza B virus. Proc. Natl Acad. Sci. USA 108, 13468-13473 (2011).
43. Sridharan, H., Zhao, C. & Krug, R. M. Species specificity of the NS1 protein of influenza B virus: NS1 binds only human and non-human primate ubiquitin-like ISG15 proteins. J. Biol. Chem. 285, 7852-7856 (2010).
44. Eduardo-Correia, B., Martinez-Romero, C., Garcia-Sastre, A. & Guerra, S. ISG15 is counteracted by vaccinia virus E3 protein and controls the proinflammatory response against viral infection. J. Virol. 88, 2312-2318 (2014).
45. Bailey-Elkin, B. A., van Kasteren, P. B., Snijder, E. J., Kikkert, M. & Mark, B. L. Viral OTU deubiquitinases: A structural and functional comparison. PLoS Pathog. 10, e1003894 (2014).
46. Mielech, A. M., Chen, Y., Mesecar, A. D. & Baker, S. C. Nidovirus papain-like proteases: multifunctional enzymes with protease, deubiquitinating and deISGylating activities. Virus Res. 194, 184-190 (2014).
47. Hwang, S. et al. Nondegradative role of Atg5-Atg12/Atg16L1 autophagy protein complex in antiviral activity of interferon gamma. Cell Host Microbe 11, 397-409 (2012).
48. Stojdl, D. F. et al. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4, 263-275 (2003).
49. Benboudjema, L., Mulvey, M., Gao, Y., Pimplikar, S. W. & Mohr, I. Association of the herpes simplex virus type 1 Us11 gene product with the cellular kinesin light-chain-related protein PAT1 results in the redistribution of both polypeptides. J. Virol. 77, 9192-9203 (2003).
50. Gardner, T. J. et al. Development of a high-Throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies. Clin. Vaccine Immunol. 20, 540-550 (2013).
51. Heaton, N. S. et al. In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies. J. Virol. 87, 8272-8281 (2013).
52. Pernet, O. et al. Evidence for henipavirus spillover into human populations in Africa. Nat. Commun. 5, 5342 (2014).
53. Francois-Newton, V. et al. USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon alpha response. PLoS ONE 6, e22200 (2011).
54. D'Cunha, J. et al. In vitro and in vivo secretion of human ISG15, an IFNinduced immunomodulatory cytokine. J. Immunol. 157, 4100-4108 (1996).
55. Loeb, K. R. & Haas, A. L. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J. Biol. Chem. 267, 7806-7813 (1992).
56. Ketscher, L. et al. Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance. Proc. Natl Acad. Sci. USA 112, 1577-1582 (2015).
57. Terenzi, F., White, C., Pal, S., Williams, B. R. & Sen, G. C. Tissue-specific and inducer-specific differential induction of ISG56 and ISG54 in mice. J. Virol. 81, 8656-8665 (2007).
58. Park, C., Li, S., Cha, E. & Schindler, C. Immune response in Stat2 knockout mice. Immunity 13, 795-804 (2000).
59. Wedeking, T. et al. Spatiotemporally controlled reorganization of signaling complexes in the plasma membrane of living cells. Small 11, 5912-5918 (2015).